Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 2 art units • 4 examiners • 0 of 5 (0%) have an AI response strategy ready
Arc Bio LLC is navigating 5 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are handled by 4 distinct examiners, with the workload concentrated in 2 distinct art units.
The busiest examiner is PARISI, JESSICA DANIELLE, who is responsible for 2 pending office actions. The focus on 2 art units suggests that despite having 4 examiners, the technical subject matter is relatively consistent across the 5 pending office actions currently in prosecution.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (40%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PARISI, JESSICA DANIELLE | 2 | 75.0% | +33.5% |
| FLINDERS, JEREMY C | 1 | 63.5% | +17.0% |
| MINCHELLA, KAITLYN L | 1 | 26.4% | +21.7% |
| LIU, GUOZHEN | 1 | 48.1% | +26.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18734997 | PRE-LIBRARY DEPLETION OF NUCLEIC ACIDS | FLINDERS, JEREMY C | — |
| 18599123 | COMPOSITIONS AND METHODS FOR MAKING GUIDE NUCLEIC ACIDS | PARISI, JESSICA DANIELLE | — |
| 18414259 | LIGATION FREE METHODS OF NUCLEIC ACID LIBRARY PREPARATION | PARISI, JESSICA DANIELLE | — |
| 18395416 | SYSTEMS AND METHODS FOR GENOMIC ANALYSIS | MINCHELLA, KAITLYN L | — |
| 16096114 | MACHINE LEARNING TECHNIQUES FOR ANALYSIS OF STRUCTURAL VARIANTS | LIU, GUOZHEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18734997 | PRE-LIBRARY DEPLETION OF NUCLEIC ACIDS | FLINDERS, JEREMY C | — |
| 18599123 | COMPOSITIONS AND METHODS FOR MAKING GUIDE NUCLEIC ACIDS | PARISI, JESSICA DANIELLE | — |
| 18414259 | LIGATION FREE METHODS OF NUCLEIC ACID LIBRARY PREPARATION | PARISI, JESSICA DANIELLE | — |
| 18395416 | SYSTEMS AND METHODS FOR GENOMIC ANALYSIS | MINCHELLA, KAITLYN L | — |
| 16096114 | MACHINE LEARNING TECHNIQUES FOR ANALYSIS OF STRUCTURAL VARIANTS | LIU, GUOZHEN | — |
| Art Unit | Apps |
|---|---|
| 1684 | 2 |
| 1686 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18734997 | PRE-LIBRARY DEPLETION OF NUCLEIC ACIDS | FLINDERS, JEREMY C | — | §102§103 | Non-Final OA | — | Pending | Jun 05, 2024 |
| 18599123 | COMPOSITIONS AND METHODS FOR MAKING GUIDE NUCLEIC ACIDS | PARISI, JESSICA DANIELLE | 1684 | §102§103§112 | Non-Final OA | — | Pending | Mar 07, 2024 |
| 18414259 | LIGATION FREE METHODS OF NUCLEIC ACID LIBRARY PREPARATION | PARISI, JESSICA DANIELLE | 1684 | §102§103 | Non-Final OA | — | Pending | Jan 16, 2024 |
| 18395416 | SYSTEMS AND METHODS FOR GENOMIC ANALYSIS | MINCHELLA, KAITLYN L | — | §101§102§103§112Other | Non-Final OA | — | Pending | Dec 22, 2023 |
| 16096114 | MACHINE LEARNING TECHNIQUES FOR ANALYSIS OF STRUCTURAL VARIANTS | LIU, GUOZHEN | 1686 | §101§103§112 | Non-Final OA | — | Pending | Oct 24, 2018 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialArc Bio LLC has 5 pending office actions as of October 2026, spread across 2 art units and 4 examiners.
Jessica Danielle Parisi has the most, with 2 of Arc Bio LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
